Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
17-Jun-25 | Buy | Heather Preston | 324.00p | 11,389 | £36,900.36 |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
17-Jun-25 | Buy | Heather Preston | 324.00p | 11,389 | £36,900.36 |
Notifier | Holding | Value* |
---|---|---|
Roch Doliveux | 309,808 | £954,209 |
Heather Preston | 29,687 | £91,436 |
Frank Mathias | 20,000 | £61,600 |
Namrata P Patel | 9,170 | £28,244 |
Dame Kay Davies | 1,000 | £3,080 |
Notifier** | Holding | Value* |
---|---|---|
Briarwood Chase Management LLC | 13,851,927 | £42,663,935 |
Novo Nordisk Foundation | 12,048,802 | £37,110,310 |
Briarwood Chase Management LLC | 11,171,966 | £34,409,655 |
VULPES LIFE SCIENCES FUND | 8,426,390 | £25,953,281 |
Institut Merieux SA | 6,309,374 | £19,432,872 |
Liontrust Asset Management | 6,078,799 | £18,722,701 |
Legal & General Group Plc | 5,760,126 | £17,741,188 |
M&G Plc | 5,324,435 | £16,399,260 |
HSBC Global Custody Nominee (UK) Ltd | 4,700,000 | £14,476,000 |
Ameriprise Financial, Inc. | 4,108,146 | £12,653,090 |
Canaccord Genuity Group Inc | 3,699,438 | £11,394,269 |
Hargreaves Lansdown Asset Management | 3,689,888 | £11,364,855 |
SERUM LIFE SCIENCES LTD | 3,382,950 | £10,419,486 |
Columbia Threadneedle Investments (London) | 3,245,381 | £9,995,774 |
Nine Ten Capital | 3,117,228 | £9,601,062 |
Lansdowne Partners (London) | 3,085,765 | £9,504,156 |
Mr. S Shah | 2,898,750 | £8,928,150 |
Artisan Partners | 2,620,800 | £8,072,064 |
Cubana Investments Limited | 2,506,000 | £7,718,480 |
Interactive Investor Sharedealing | 2,372,412 | £7,307,029 |
TDWaterhouse | 852,076 | £2,624,394 |
Self Trade Stockbrokers | 657,039 | £2,023,680 |
Currency | UK Pounds |
Share Price | 308.00p |
Change Today | 1.00p |
% Change | 0.33 % |
52 Week High | 445.00 |
52 Week Low | 232.50 |
Volume | 28,126 |
Shares Issued | 106.09m |
Market Cap | £326.77m |
Beta | 0.00 |
RiskGrade | 125 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 3 |
Buy | 2 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 9 |
No dividends found |
Time | Volume / Share Price |
10:54 | 100 @ 308.00p |
10:54 | 100 @ 308.00p |
10:53 | 100 @ 308.00p |
10:52 | 100 @ 308.00p |
10:52 | 27 @ 308.50p |
Chair | Roch Doliveux |
CEO | Frank Mathias |
CFO | Lucinda (Lucy) Crabtree |
You are here: research